Arbutus Biopharma Balance Sheet (2010-2025) | ABUS

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Balance Sheet	Mar2021	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025
Accumulated Depreciation (Quarter)
Receivables - Accured (Quarter)								0.60M	0.60M	0.60M	0.60M	0.60M	0.60M	0.30M	0.30M	0.30M	0.20M	0.10M	0.30M	0.30M
Assets
Current Assets
Cash & Equivalents (Quarter)	79.42M	30.95M	77.88M	109.28M	81.33M	47.32M	24.00M	30.78M	40.57M	27.20M	17.53M	26.29M	43.10M	62.79M	31.85M	36.33M	26.38M	37.41M	22.41M	18.01M
Receivables - Net (Quarter)	1.26M	1.30M	1.67M	0.90M	1.31M	1.97M	1.83M	1.35M	2.66M	2.61M	2.17M	1.78M	2.14M	1.77M	1.61M	2.41M	1.18M	1.02M	0.91M	1.45M
Receivables - Other (Quarter)
Receivables (Quarter)	1.26M	1.30M	1.67M	0.90M	1.31M	1.97M	1.83M	1.35M	2.66M	2.61M	2.17M	1.78M	2.14M	1.77M	1.61M	2.41M	1.18M	1.02M	0.91M	1.45M
Finished Goods (Quarter)
Prepaid Assets (Quarter)	4.12M	3.79M	3.47M	4.45M	5.91M	5.62M	4.58M	2.87M	3.46M	3.70M	5.26M	4.25M	4.49M	4.47M	3.38M	2.28M	2.92M	4.01M	2.83M	1.54M
Current Deferred Tax Assets (Quarter)
Current Assets (Quarter)	137.34M	83.47M	126.54M	160.66M	172.70M	157.79M	141.14M	151.14M	152.85M	158.80M	141.61M	132.03M	135.87M	148.22M	132.78M	127.32M	116.81M	103.12M	97.44M	94.46M
Non-Current Assets
Property, Plant & Equipment (Net) (Quarter)	6.58M	6.78M	6.35M	5.98M	5.66M	5.49M	5.24M	5.07M	4.85M	5.37M	5.03M	4.67M	4.41M	4.06M	3.56M	3.31M	0.17M	0.15M	0.14M	0.03M
Long-Term Investments (Quarter)	35.69M	35.69M	35.69M	35.69M	37.36M	50.45M	55.44M	37.36M	31.79M	11.06M	10.50M	6.28M	8.68M	6.53M	2.96M
Goodwill (Quarter)
Intangibles (Quarter)
Goodwill & Intangibles (Quarter)
Long-Term Deferred Tax (Quarter)
Other Non-Current Assets (Quarter)				0.06M	0.19M	0.18M	0.17M	0.10M	0.06M	0.01M	0.00M					0.03M	0.03M		0.13M	0.13M
Non-Current Assets (Quarter)	8.90M	51.91M	39.06M	43.82M	64.18M	58.05M	62.66M	44.28M	38.37M	18.02M	17.03M	12.37M	14.42M	11.82M	7.66M	4.39M	0.20M	0.15M	0.27M	0.16M
Assets (Quarter)	146.24M	135.38M	165.60M	204.49M	236.88M	215.84M	203.80M	195.42M	191.22M	176.82M	158.64M	144.40M	150.29M	160.04M	140.44M	131.71M	117.01M	103.27M	97.71M	94.62M
Liabilities
Current Liabilities
Accounts Payables (Quarter)	6.06M	8.35M	9.73M	10.84M	8.71M	12.47M	12.27M	16.03M	9.65M	8.80M	9.81M	10.27M	8.25M	11.11M	7.54M	7.56M	12.11M	4.51M	4.65M	5.46M
Payables (Quarter)	6.06M	8.35M	9.73M	10.84M	8.71M	12.47M	12.27M	16.03M	9.65M	8.80M	9.81M	10.27M	8.25M	11.11M	7.54M	7.56M	12.11M	4.51M	4.65M	5.46M
Accumulated Expenses (Quarter)
Other Accumulated Expenses (Quarter)
Current Leases (Quarter)	0.43M	0.36M	0.39M	0.38M	0.44M	0.38M	0.36M	0.37M	0.45M	0.40M	0.41M	0.42M	0.50M	0.45M	0.47M	0.48M	0.56M	0.51M	0.53M	0.55M
Current Deferred Revenue (Quarter)					23.25M	16.97M	14.88M	16.46M	15.05M	15.33M	12.11M	11.79M	11.55M	11.03M	10.91M	7.57M	6.76M
Total Current Liabilities (Quarter)	6.69M	8.84M	10.11M	11.22M	32.41M	29.82M	27.51M	32.86M	25.15M	24.53M	22.32M	22.49M	20.30M	22.59M	18.92M	15.62M	19.43M	5.02M	5.18M	6.01M
Non-Current Liabilities
Non-Current Debt (Quarter)
Non-Current Deffered Revenue (Quarter)					15.59M	10.84M	10.59M	6.00M	3.30M							2.86M	2.86M
Operating Leases (Quarter)	2.48M	2.48M	2.35M	2.23M	2.10M	2.09M	1.96M	1.81M	1.67M	1.65M	1.50M	1.34M	1.18M	1.14M	0.98M	0.81M	0.63M	0.57M	0.39M	0.20M
Non-Current Deferred Tax Liability (Quarter)
Other Non-Current Liabilities (Quarter)	19.37M	4.25M	5.11M	16.30M	3.63M	14.23M	5.92M	7.53M	7.80M	8.79M	7.37M	7.60M	7.78M	7.99M	8.34M	4.83M	4.41M	10.80M	11.05M	3.44M
Total Non-Current Liabilities (Quarter)	12.72M	30.30M	30.35M	18.75M	67.41M	48.46M	52.36M	51.04M	39.51M	33.34M	31.93M	30.78M	27.87M	29.60M	25.22M	29.51M	33.44M	9.49M	9.26M	14.60M
Total Liabilities (Quarter)	32.09M	34.55M	35.46M	35.05M	71.03M	62.69M	58.28M	58.57M	47.31M	42.13M	39.30M	38.38M	35.65M	37.59M	33.55M	34.34M	37.85M	20.29M	20.31M	18.04M
Shareholder's Equity
Total Debt (Quarter)
Common Equity (Quarter)	114.15M	100.83M	130.14M	169.44M	165.84M	153.14M	145.52M	136.85M	143.91M	134.69M	119.34M	106.02M	114.64M	122.45M	106.89M	97.37M	79.16M	82.98M	77.40M	76.58M
Shareholder's Equity (Quarter)	114.15M	100.83M	130.14M	169.44M	165.84M	153.14M	145.52M	136.85M	143.91M	134.69M	119.34M	106.02M	114.64M	122.45M	106.89M	97.37M	79.16M	82.98M	77.40M	76.58M
Liabilities and Shareholders Equity (Quarter)	146.24M	135.38M	165.60M	204.49M	236.88M	215.84M	203.80M	195.42M	191.22M	176.82M	158.64M	144.40M	150.29M	160.04M	140.44M	131.71M	117.01M	103.27M	97.71M	94.62M
Retained Earnings (Quarter)	-48.17M	-1088.21M	-1112.45M	-48.34M	-1150.11M	-50.10M	-1181.87M	-50.49M	-49.63M	-49.47M	-48.88M	-48.42M	-48.37M	-48.31M	-1334.04M	-1346.57M	-1371.10M	-48.19M	-1376.32M	-48.10M
Preferred Shares (Quarter)	152.62M	155.89M	160.97M
Treasury Shares (Quarter)												1.23M
Shares Outstanding (Quarter)	96.25M	97.70M	110.26M	144.99M	148.73M	148.79M	152.71M	157.46M	165.13M	166.92M	167.70M	169.87M	180.19M	188.74M	189.44M	189.96M	191.48M	191.64M	191.95M	192.53M

Research Tools

Arbutus Biopharma Balance Sheet (2010-2025) | ABUS

Create an account

Sign In

Reset Password